A toolkit to address disparities in digitally enabled oncology trials By Ogkologos - September 5, 2025 673 0 Facebook Twitter Google+ Pinterest WhatsApp An initiative fosters inclusive research by improving patient access and participation in cancer research Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Olanzapine Reduces Nausea and Vomiting Caused by Advanced Cancer June 12, 2020 Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy... July 12, 2024 Belantamab Mafodotin–Containing Triplets Confer a Significant PFS Benefit Among Previously Treated... July 3, 2024 Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among... August 25, 2025 Load more HOT NEWS Clinical Trial Results Support Uninterrupted Use of Imatinib for Some Gastrointestinal... Tables Turned EMA Recommends Granting a Conditional Marketing Authorisation for Talquetamab EMA Recommends Extension of Therapeutic Indications for Tremelimumab
